Collegium Pharmaceutical
COLL
SilverCrest Metals
SILV
Cars.com
CARS
Halozyme Therapeutics
HALO
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
US Stock MarketDetailed Quotes
DSX Diana Shipping
- 1.875
- -0.005-0.27%
Trading Dec 26 12:57 ET
234.72MMarket Cap37.50P/E (TTM)
1.900High1.860Low341.29KVolume1.870Open1.880Pre Close640.65KTurnover0.60%Turnover Ratio4.46P/E (Static)125.19MShares3.02552wk High0.47P/B106.17MFloat Cap1.72152wk Low0.38Dividend TTM56.62MShs Float23.456Historical High20.00%Div YieldTTM2.13%Amplitude0.810Historical Low1.877Avg Price1Lot Size
Diana Shipping Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -7.37%57.49M | -16.89%56M | -20.64%57.65M | -9.61%262.1M | -20.72%60.02M | -15.92%62.06M | -9.59%67.38M | 10.18%72.64M | 35.37%289.97M | 9.96%75.71M |
| Operating revenue | -7.37%57.49M | -16.89%56M | -20.64%57.65M | -9.61%262.1M | -20.72%60.02M | -15.92%62.06M | -9.59%67.38M | 10.18%72.64M | 35.37%289.97M | 9.96%75.71M |
| Cost of revenue | 1.01%36.11M | -10.47%35.42M | -5.36%35.23M | 21.74%148.89M | 5.07%36.35M | 12.57%35.75M | 41.24%39.56M | 33.27%37.23M | 1.23%122.3M | 18.89%34.6M |
| Gross profit | -18.75%21.38M | -26.02%20.58M | -36.71%22.41M | -32.48%113.21M | -42.44%23.66M | -37.43%26.31M | -40.19%27.82M | -6.81%35.41M | 79.55%167.67M | 3.43%41.11M |
| Operating expense | 4.22%8.9M | 0.71%8.43M | 10.20%8.58M | 10.82%32.82M | 5.86%8.13M | 20.22%8.54M | 10.38%8.37M | 12.27%7.79M | -5.17%29.61M | -11.46%7.68M |
| Selling and administrative expenses | -5.89%8.38M | 2.28%8.2M | 11.08%8.53M | 12.26%32.97M | 12.92%8.36M | 27.04%8.91M | 1.58%8.01M | 8.83%7.68M | 0.60%29.37M | 6.79%7.41M |
| -General and administrative expense | -5.89%8.38M | 2.28%8.2M | 11.08%8.53M | 12.26%32.97M | 12.92%8.36M | 27.04%8.91M | 1.58%8.01M | 8.83%7.68M | 0.60%29.37M | 6.79%7.41M |
| Other operating expenses | 239.19%515K | -35.13%229K | -54.29%48K | -161.38%-151K | -187.78%-237K | -511.11%-370K | 214.24%353K | 185.37%105K | -87.91%246K | -84.44%270K |
| Operating profit | -29.79%12.48M | -37.51%12.16M | -49.93%13.83M | -41.77%80.39M | -53.53%15.54M | -49.15%17.77M | -50.03%19.45M | -11.06%27.63M | 122.11%138.06M | 7.59%33.43M |
| Net non-operating interest income expense | 5.46%-9.97M | 6.47%-9.55M | -4.41%-10.32M | -66.77%-41.16M | -26.57%-10.52M | -82.23%-10.54M | -82.38%-10.22M | -98.31%-9.88M | -23.02%-24.68M | -62.32%-8.31M |
| Non-operating interest income | -2.75%2.23M | 3.45%2.04M | -2.14%1.74M | 198.50%8.17M | 43.43%2.13M | 264.29%2.3M | 412.21%1.97M | 645.38%1.77M | 1,455.11%2.74M | 1,430.93%1.49M |
| Non-operating interest expense | -4.98%12.2M | -15.15%10.34M | 3.41%12.06M | 87.73%46.4M | 37.01%9.72M | 100.11%12.84M | 103.59%12.19M | 123.25%11.66M | 36.81%24.72M | 133.00%7.1M |
| Total other finance cost | ---- | ---- | ---- | 8.40%2.93M | ---- | ---- | ---- | ---- | 24.36%2.7M | ---- |
| Other net income (expense) | 675.48%1.2M | -577.07%-5.37M | -129.27%-1.46M | 86.67%10.62M | 672.57%4.37M | -93.96%155K | -50.48%1.13M | 14,302.86%4.97M | -62.83%5.69M | -96.28%565K |
| Gain on sale of security | 211.76%477K | -827.07%-5.53M | ---2.63M | 250.44%5.2M | --4.28M | --153K | --761K | ---- | 545.35%1.48M | ---- |
| Earnings from equity interest | -1,450.00%-27K | -25.89%166K | -2,085.00%-397K | ---- | ---- | 103.17%2K | -72.03%224K | 157.14%20K | ---- | ---- |
| Special income (charges) | --752K | --0 | -68.25%1.57M | 28.90%5.42M | 253.27%328K | --0 | -90.48%140K | --4.95M | -73.11%4.2M | -101.40%-214K |
| -Less:Other special charges | --3.48M | ---- | ---- | 155.24%748K | --0 | ---- | 147.86%704K | --44K | -238.16%-1.35M | --223K |
| -Gain on sale of business | --0 | ---- | ---- | --844K | --0 | --0 | --844K | ---- | --0 | --0 |
| -Gain on sale of property,plant,equipment | --4.23M | --0 | -68.53%1.57M | 86.77%5.32M | 3,544.44%328K | --0 | --0 | --5M | 109.56%2.85M | --9K |
| Income before tax | -49.70%3.72M | -126.67%-2.76M | -90.94%2.06M | -58.14%49.84M | -63.47%9.38M | -76.72%7.39M | -70.89%10.36M | -12.79%22.71M | 107.45%119.06M | -37.57%25.68M |
| Income tax | ||||||||||
| Net income | -49.70%3.72M | -126.67%-2.76M | -90.94%2.06M | -58.14%49.84M | -63.47%9.38M | -76.72%7.39M | -70.89%10.36M | -12.79%22.71M | 107.45%119.06M | -37.57%25.68M |
| Net income continuous Operations | -49.70%3.72M | -126.67%-2.76M | -90.94%2.06M | -58.14%49.84M | -63.47%9.38M | -76.72%7.39M | -70.89%10.36M | -12.79%22.71M | 107.45%119.06M | -37.57%25.68M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -49.70%3.72M | -126.67%-2.76M | -90.94%2.06M | -58.14%49.84M | -63.47%9.38M | -76.72%7.39M | -70.89%10.36M | -12.79%22.71M | 107.45%119.06M | -37.57%25.68M |
| Preferred stock dividends | 0.07%1.44M | 0.00%1.44M | 0.00%1.44M | 0.00%5.77M | 0.00%1.44M | 0.00%1.44M | 0.00%1.44M | 0.00%1.44M | 0.00%5.77M | 0.00%1.44M |
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -61.78%2.27M | -147.14%-4.21M | -97.10%616K | -61.10%44.08M | -67.25%7.94M | -80.38%5.94M | -73.88%8.92M | -13.54%21.27M | 119.46%113.29M | -38.94%24.24M |
| Basic earnings per share | -66.67%0.02 | -144.44%-0.04 | -95.45%0.01 | -69.01%0.44 | -71.43%0.08 | -84.62%0.06 | -79.55%0.09 | -31.25%0.22 | 121.88%1.42 | -45.10%0.28 |
| Diluted earnings per share | -68.50%0.0189 | -144.44%-0.04 | -95.45%0.01 | -69.12%0.42 | -77.78%0.06 | -83.78%0.06 | -78.57%0.09 | -29.03%0.22 | 122.95%1.36 | -43.75%0.27 |
| Dividend per share | -50.00%0.075 | -50.00%0.075 | -50.00%0.075 | -33.33%0.6 | -14.29%0.15 | -45.45%0.15 | -40.00%0.15 | -25.00%0.15 | 800.00%0.9 | 75.00%0.175 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
